http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03130228-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17369e28baa208b320799cc7d72a8259
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1990-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41db00e1ab00d19f691d789cabdb2e2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff2b1a599c1684cb22058a3e0ca7e3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd0bd5bdb87046b14d855fac280825f
publicationDate 1991-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03130228-A
titleOfInvention Local therapeutic agent for psoriasis and its production
abstract PURPOSE: To obtain a local therapeutic agent for psoriasis slight in adverse effect, containing a specific alkyl phosphate compound. n CONSTITUTION: This therapeutic agent comprises a compound of formula I [R is a 12-24C hydrocarbon group or a group of formula II (R 3 is a 1-6C alkoxy or a 1-6C alkoxymethyl; Z is O or S; R 4 is a 1-24C alkyl); X is O, NH or NR 2 (R 2 is 2,3-dihydroxypropyl, a 1-8C alkyl or an unsaturated and/or substituted 2-8C alkyl); Y is O or NH; R 1 is a 1-8C alkyl or an unsaturated and/or substituted 2-8C alkyl and when X is O, R 1 is 2-t-butyloxycarbonylaminomethyl, 2,3-dibenzoyloxy-propyl (2), etc., and when X is NH, R 1 is 2,3-dihydroxypropyl (1)] such as hexadecyl phosphocholine. The compound is used with an alkylglycerol of formula III (one or R 5 and R 6 is a 2-12C alkyl and the other is H) to improve the action of the compound of formula I. n COPYRIGHT: (C)1991,JPO
priorityDate 1989-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10126848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227294378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11297987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15390

Total number of triples: 45.